Markus Matilainen
PhD
Turku PET Centre manmat@utu.fi +358 29 450 4739 +358 50 472 8469 Itäinen Pitkäkatu 4 Turku ORCID identifier: https://orcid.org/0000-0002-5597-2670 |
Areas of expertise
Statistics; Biostatistics; Blind Source Separation
Statistics; Biostatistics; Blind Source Separation
Publications
- Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study (2026)
- Journal of Neurology
(A1 Refereed original research article in a scientific journal) - Real-world detection of paramagnetic rim lesions and their association with disease burden in multiple sclerosis (2026)
- Multiple Sclerosis and Related Disorders
(A1 Refereed original research article in a scientific journal) - A nationwide comparison of public and private treatment of Achilles tendon rupture in Finland (2025)
- Scandinavian Journal of Surgery
(A1 Refereed original research article in a scientific journal) - Broad rim lesions are a new pathological and imaging biomarker for rapid disease progression in multiple sclerosis (2025)
- Nature Medicine
(A1 Refereed original research article in a scientific journal) - Hemispheric asymmetry of [11C](R)PK11195 binding to translocator protein 18 kDa (TSPO) in normal brain (2025)
- Journal of Cerebral Blood Flow and Metabolism
(A1 Refereed original research article in a scientific journal) - Integrating TSPO-PET imaging with metabolomics for enhanced prognostic accuracy in multiple sclerosis (2025)
- BMJ neurology open
(A1 Refereed original research article in a scientific journal) - Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis (2025)
- Journal of Neuroinflammation
(A1 Refereed original research article in a scientific journal) - Plasma CHI3L1 associates with brain volume loss and glial activation in multiple sclerosis (2025)
- Journal of Neurology, Neurosurgery and Psychiatry
(A1 Refereed original research article in a scientific journal) - Predictors of risk of secondary progression in multiple sclerosis (2025)
- Therapeutic Advances in Neurological Disorders
(A1 Refereed original research article in a scientific journal) - Serum glial fibrillary acid protein associates with TSPO-expressing lesions in multiple sclerosis brain (2025)
- Therapeutic Advances in Neurological Disorders
(A1 Refereed original research article in a scientific journal)



